Clinical Trial Update: Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating a triple combination of tocilizumab, ipilimumab, and nivolumab for advanced melanoma, non-small cell lung cancer, or ur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Non-small Cell Lung Cancer
• Urothelial Carcinoma

Drugs mentioned

• Actemra (tocilizumab)
• OPDIVO (nivolumab)
• Yervoy (ipilimumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 | Phase 2 | Status: ACTIVE_NOT_RECRUITING